Observational studyInternational journal of molecular sciences2025

Serum IL-18/IL-13 Ratio Predicts Super Response to Secukinumab in Patients with Psoriasis.

Dominika Ziolkowska-Banasik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.